Learn why optimal use of pharmacotherapy is an important component of tobacco dependence treatment.
Dr. Hays has over 25 years of experience in treating tobacco dependence and researching new approaches to this treatment. This broad experience allows him to blend both the “art and science” of medicine and use it for the good of his patients.
The focus areas for his research include:
- Study of the nicotine receptor partial agonist varenicline for tobacco dependence treatment
- Study of the treatment of tobacco dependence among smokers with current or past alcohol abuse or dependence
- Dissemination of evidence-based tobacco dependence treatment to health care providers within and outside the United States.
Tobacco use and dependence remain the number one cause of preventable and premature death in the United States. Dr. Hays focuses on effective treatments to help tobacco-dependent patients become smoke-free and reduce their risk of premature death.
Associate Director, Nicotine Dependence Center, Mayo Clinic
Chair, Personnel Committee, Mayo Clinic in Rochester, Minn.
Distinguished Clinician Award, Mayo Clinic, 2011
Diplomate, American Board of Addiction Medicine, 2010
Fellow, American College of Physicians, 2008
Board certification in Internal Medicine and Addiction Medicine
On the staff of Mayo Clinic since 1991
Internal Medicine Residency 1980-1984 Vanderbilt University
Professor of Medicine
MD – 1980 Vanderbilt University Medical School